Venture Life Announces Total Voting Rights Update

Venture Life ( (GB:VLG) ) has shared an update.

Venture Life Group PLC announced its total voting rights as of 30 November 2025, with 127,675,994 ordinary shares carrying voting rights out of a total issued share capital of 128,052,312 shares. This information is crucial for shareholders to determine their interest in the company’s share capital under the FCA’s Disclosure and Transparency Rules.

The most recent analyst rating on (GB:VLG) stock is a Hold with a £57.00 price target. To see the full list of analyst forecasts on Venture Life stock, see the GB:VLG Stock Forecast page.

Spark’s Take on GB:VLG Stock

According to Spark, TipRanks’ AI Analyst, GB:VLG is a Neutral.

Venture Life’s overall stock score is primarily impacted by financial performance challenges, including declining revenues and profitability. Technical analysis indicates a lack of strong momentum, and the high P/E ratio suggests overvaluation concerns. The absence of earnings call data and corporate events means these factors do not influence the score.

To see Spark’s full report on GB:VLG stock, click here.

More about Venture Life

Venture Life is an international consumer self-care company headquartered in the UK, focusing on commercializing products for the global self-care market. Its product portfolio includes Balance Activ for women’s intimate healthcare, Earol® for ENT care, Lift and Glucogel for energy and glucose management, and Health & Her for the hormonal lifecycle. These products are recommended by healthcare professionals and sold through various channels including health & beauty stores, pharmacies, grocery multiples, and e-commerce platforms globally.

Average Trading Volume: 168,022

Technical Sentiment Signal: Buy

Current Market Cap: £77.93M

Find detailed analytics on VLG stock on TipRanks’ Stock Analysis page.